4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated and 4-Nonylphenol, branched and linear, ethoxylated

Request

Summary

European Chemicals Agency (ECHA) launched a public consultation on 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated and 4-Nonylphenol, branched and linear, ethoxylated: used in the production of various medical devices (e.g. in vitro diagnostic) and medicinal products.


Description

ECHA launched a public consultation on 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated and 4-Nonylphenol, branched and linear, ethoxylated: used in the production of various medical devices (e.g. in vitro diagnostic) and medicinal products.

The formal public consultation period for this substance is over. However, if you have a potential alternative, you can find the list of applicants/authorisation holders from our current consultations page, or you can browse for previous consultations. We also recommend checking our list of downstream uses covered by granted authorisations where you can find potential candidates for alternatives.

More about the applications for authorisation process

About public consultations on alternatives in applications for authorisation

The purpose of public consultations is to gather additional relevant and meaningful information on possible alternatives for the uses applied for. It offers the opportunity for public engagement in the regulatory process.

The information submitted will be taken into account in the development of the opinion for the relevant applications for authorisation by ECHA’s Committee for Risk Assessment (RAC) and the Committee for Socio-Economic Analysis (SEAC).

About ECHA

ECHA is the driving force among regulatory authorities in implementing the EU's ground-breaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness. ECHA helps companies to comply with the legislation, advances the safe use of chemicals, provides information on chemicals and addresses chemicals of concern.


Alternative should replace

4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated and 4-Nonylphenol, branched and linear, ethoxylated: used in the production of various medical devices (e.g. in vitro diagnostic) and medicinal products.


European Chemicals Agency
Company
European Chemicals Agency
Contact
ECHA


Comment or report this ad to ChemSec